Draxis posts higher revenues in Q2

Canadian radiopharmaceutical developer Draxis Health posted a 4% increase in second-quarter revenues of $9.8 million (U.S.) from $9.4 million in the same period last year.

For the period (end-June 30), the Mississauga, Ontario-based firm also reported an operating profitability of $1.6 million, up 23% compared to results in the second quarter of 2000. Revenues have increased 12% to date, from $17.6 million in 2000 to $19.7 million in 2001, according to Draxis. (All figures are expressed in U.S. dollars.)

By AuntMinnie.com staff writers
August 13, 2001

Related Reading

Draxis posts mixed Q3 results, November, 8, 2000

Draxis gets Canadian OK for BrachySeed, October 10, 2000

DraxImage gets NRC approval for BrachySeed, September 22, 2000

Draxis signs brachytherapy seed agreement with Cytogen, September 14, 2000

Draxis to emphasize radiopharmaceuticals, July 19, 2000

Copyright © 2001 AuntMinnie.com

Page 1 of 461
Next Page